BioCentury | Sep 28, 2018
Finance

Morphic reloads

...existing investors SR One, Pfizer Ventures, AbbVie Ventures, Polaris Partners, computational chemistry company Schrödinger Inc., ShangPharma Innovation Inc....
BioCentury | Sep 28, 2018
Financial News

Morphic's $80M round paves way for integrin clinical studies

...One, Pfizer Ventures, AbbVie Ventures, Polaris Partners, computational chemistry company Schrödinger Inc. (New York, N.Y.), ShangPharma Innovation Inc....
BioCentury | Sep 25, 2018
Financial News

Morphic's $80M round paves way for integrin clinical studies

...One, Pfizer Ventures, AbbVie Ventures, Polaris Partners, computational chemistry company Schrödinger Inc. (New York, N.Y.), ShangPharma Innovation Inc....
BioCentury | Jan 19, 2018
Company News

ShangPharma, Icahn in R&D deal

...provide CRO services during the multi-year partnership. Both are affiliated with ShangPharma Corp. (Shanghai, China). ShangPharma Innovation Inc....
BioCentury | Oct 19, 2017
Finance

Broad umbrella

...partnership Umbrella agreement June 2017 The Scripps Research Institute, California Institute for Biomedical Research (Calibr) ShangPharma Innovation Inc....
BioCentury | Jul 21, 2017
Company News

ShangPharma, UCSF partner to accelerate research

...Under a new partnership, ShangPharma Innovation Inc. (South San Francisco, Calif.) will fund preclinical research at the University...
...the collaboration will advance its new initiative to boost industry investment in innovative research programs. ShangPharma Innovation Inc....
...Francisco , San Francisco, Calif. Business: Pharmaceuticals Alex Himes ShangPharma Corp. UCSF University of California San Francisco Shanghai ChemPartner Co. Ltd. ShangPharma Innovation Inc....
BioCentury | Jul 18, 2017
Company News

UCSF and ShangPharma collaborate to accelerate research

...Under a new partnership, ShangPharma Innovation Inc. (South San Francisco, Calif.) will fund preclinical research at the University...
Items per page:
1 - 7 of 7
BioCentury | Sep 28, 2018
Finance

Morphic reloads

...existing investors SR One, Pfizer Ventures, AbbVie Ventures, Polaris Partners, computational chemistry company Schrödinger Inc., ShangPharma Innovation Inc....
BioCentury | Sep 28, 2018
Financial News

Morphic's $80M round paves way for integrin clinical studies

...One, Pfizer Ventures, AbbVie Ventures, Polaris Partners, computational chemistry company Schrödinger Inc. (New York, N.Y.), ShangPharma Innovation Inc....
BioCentury | Sep 25, 2018
Financial News

Morphic's $80M round paves way for integrin clinical studies

...One, Pfizer Ventures, AbbVie Ventures, Polaris Partners, computational chemistry company Schrödinger Inc. (New York, N.Y.), ShangPharma Innovation Inc....
BioCentury | Jan 19, 2018
Company News

ShangPharma, Icahn in R&D deal

...provide CRO services during the multi-year partnership. Both are affiliated with ShangPharma Corp. (Shanghai, China). ShangPharma Innovation Inc....
BioCentury | Oct 19, 2017
Finance

Broad umbrella

...partnership Umbrella agreement June 2017 The Scripps Research Institute, California Institute for Biomedical Research (Calibr) ShangPharma Innovation Inc....
BioCentury | Jul 21, 2017
Company News

ShangPharma, UCSF partner to accelerate research

...Under a new partnership, ShangPharma Innovation Inc. (South San Francisco, Calif.) will fund preclinical research at the University...
...the collaboration will advance its new initiative to boost industry investment in innovative research programs. ShangPharma Innovation Inc....
...Francisco , San Francisco, Calif. Business: Pharmaceuticals Alex Himes ShangPharma Corp. UCSF University of California San Francisco Shanghai ChemPartner Co. Ltd. ShangPharma Innovation Inc....
BioCentury | Jul 18, 2017
Company News

UCSF and ShangPharma collaborate to accelerate research

...Under a new partnership, ShangPharma Innovation Inc. (South San Francisco, Calif.) will fund preclinical research at the University...
Items per page:
1 - 7 of 7